FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899582938> ?p ?o ?g. }

• W2899582938 endingPage "332" @default.
• W2899582938 startingPage "323" @default.
• W2899582938 abstract "Betamethsone valerate (BMV), a medium potency topical corticosteroid, is one of the most commonly employed pharmacological agents for the management of atopic dermatitis in both adults and children. Despite having remarkable pharmacological efficacy, these agents have limited clinical implication due to poor penetration across the startum cornum (SC). To mitigate issues related to targeted delivery, stability, and solubility as well as to potentiate therapeutic and clinical implication, the nanodelivery systems have gained remarkable recognition. Therefore, this study was aimed to encapsulate BMV into the chitosan nanoparticles (CS-NPs) for optimum dermal targeting and improved penetration across the SC. The prepared NPs were characterized for particle size, zeta potential, polydispersity index, entrapment efficiency, loading capacity, crystallinity, thermal behavior, morphology, in vitro release kinetics, drug permeation across the SC, and percentage of drug retained into various skin layers. Results showed that optimized BMV-CS-NPs exhibited optimum physicochemical characteristics including small particle size (< 250 ± 28 nm), higher zeta potential (+58 ± 8 mV), and high entrapment efficiency (86 ± 5.6%) and loading capacity (34 ± 7.2%). The in vitro release study revealed that BMV-CS-NPs displayed Fickian-diffusion type mechanism of release in simulated skin surface (pH 5.5). Drug permeation efficiency and the amount of BMV retained into the epidermis and the dermis were comparatively higher in case of BMV-CS-NPs compared to BMV solution. Conclusively, we anticipated that BMV-CS-NPs could be a promising nanodelivery system for efficient dermal targeting of BMV and improved anti-AD efficacy." @default.
• W2899582938 created "2018-11-16" @default.
• W2899582938 creator A5001268453 @default.
• W2899582938 creator A5003874983 @default.
• W2899582938 creator A5032222232 @default.
• W2899582938 creator A5038047739 @default.
• W2899582938 creator A5046800198 @default.
• W2899582938 creator A5054556398 @default.
• W2899582938 creator A5057111968 @default.
• W2899582938 creator A5059732344 @default.
• W2899582938 creator A5060922136 @default.
• W2899582938 date "2018-11-20" @default.
• W2899582938 modified "2023-10-01" @default.
• W2899582938 title "Nanoencapsulation of betamethasone valerate using high pressure homogenization–solvent evaporation technique: optimization of formulation and process parameters for efficient dermal targeting" @default.
• W2899582938 cites W1975902610 @default.
• W2899582938 cites W1988990442 @default.
• W2899582938 cites W2006459601 @default.
• W2899582938 cites W2007207787 @default.
• W2899582938 cites W2008278254 @default.
• W2899582938 cites W2010524943 @default.
• W2899582938 cites W2013131125 @default.
• W2899582938 cites W2015700195 @default.
• W2899582938 cites W2030309081 @default.
• W2899582938 cites W2051305606 @default.
• W2899582938 cites W2053151201 @default.
• W2899582938 cites W2054164797 @default.
• W2899582938 cites W2067119243 @default.
• W2899582938 cites W2070555735 @default.
• W2899582938 cites W2090508094 @default.
• W2899582938 cites W2115741721 @default.
• W2899582938 cites W2154066481 @default.
• W2899582938 cites W2172902239 @default.
• W2899582938 cites W2326570504 @default.
• W2899582938 cites W2343893731 @default.
• W2899582938 cites W2410827846 @default.
• W2899582938 cites W2512586605 @default.
• W2899582938 cites W2516124838 @default.
• W2899582938 cites W2557843841 @default.
• W2899582938 cites W2603079770 @default.
• W2899582938 cites W2790314124 @default.
• W2899582938 doi "https://doi.org/10.1080/03639045.2018.1542704" @default.
• W2899582938 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30404554" @default.
• W2899582938 hasPublicationYear "2018" @default.
• W2899582938 type Work @default.
• W2899582938 sameAs 2899582938 @default.
• W2899582938 citedByCount "32" @default.
• W2899582938 countsByYear W28995829382019 @default.
• W2899582938 countsByYear W28995829382020 @default.
• W2899582938 countsByYear W28995829382021 @default.
• W2899582938 countsByYear W28995829382022 @default.
• W2899582938 countsByYear W28995829382023 @default.
• W2899582938 crossrefType "journal-article" @default.
• W2899582938 hasAuthorship W2899582938A5001268453 @default.
• W2899582938 hasAuthorship W2899582938A5003874983 @default.
• W2899582938 hasAuthorship W2899582938A5032222232 @default.
• W2899582938 hasAuthorship W2899582938A5038047739 @default.
• W2899582938 hasAuthorship W2899582938A5046800198 @default.
• W2899582938 hasAuthorship W2899582938A5054556398 @default.
• W2899582938 hasAuthorship W2899582938A5057111968 @default.
• W2899582938 hasAuthorship W2899582938A5059732344 @default.
• W2899582938 hasAuthorship W2899582938A5060922136 @default.
• W2899582938 hasConcept C11432220 @default.
• W2899582938 hasConcept C127413603 @default.
• W2899582938 hasConcept C147789679 @default.
• W2899582938 hasConcept C155672457 @default.
• W2899582938 hasConcept C171250308 @default.
• W2899582938 hasConcept C178790620 @default.
• W2899582938 hasConcept C185592680 @default.
• W2899582938 hasConcept C187530423 @default.
• W2899582938 hasConcept C192562407 @default.
• W2899582938 hasConcept C41625074 @default.
• W2899582938 hasConcept C42360764 @default.
• W2899582938 hasConcept C42475967 @default.
• W2899582938 hasConcept C43617362 @default.
• W2899582938 hasConcept C50670333 @default.
• W2899582938 hasConcept C55493867 @default.
• W2899582938 hasConcept C80107235 @default.
• W2899582938 hasConcept C86181022 @default.
• W2899582938 hasConceptScore W2899582938C11432220 @default.
• W2899582938 hasConceptScore W2899582938C127413603 @default.
• W2899582938 hasConceptScore W2899582938C147789679 @default.
• W2899582938 hasConceptScore W2899582938C155672457 @default.
• W2899582938 hasConceptScore W2899582938C171250308 @default.
• W2899582938 hasConceptScore W2899582938C178790620 @default.
• W2899582938 hasConceptScore W2899582938C185592680 @default.
• W2899582938 hasConceptScore W2899582938C187530423 @default.
• W2899582938 hasConceptScore W2899582938C192562407 @default.
• W2899582938 hasConceptScore W2899582938C41625074 @default.
• W2899582938 hasConceptScore W2899582938C42360764 @default.
• W2899582938 hasConceptScore W2899582938C42475967 @default.
• W2899582938 hasConceptScore W2899582938C43617362 @default.
• W2899582938 hasConceptScore W2899582938C50670333 @default.
• W2899582938 hasConceptScore W2899582938C55493867 @default.
• W2899582938 hasConceptScore W2899582938C80107235 @default.
• W2899582938 hasConceptScore W2899582938C86181022 @default.
• W2899582938 hasFunder F4320322780 @default.
• W2899582938 hasFunder F4320336012 @default.
• W2899582938 hasIssue "2" @default.

• next